/term/net-net-working-capital/XCNQ:SNN Sunniva (XCNQ:SNN) Net-Net Working Capital
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Net-Net Working Capital

Sunniva (XCNQ:SNN) Net-Net Working Capital : C$-1.82 (As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Sunniva Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Sunniva's Net-Net Working Capital for the quarter that ended in Sep. 2019 was C$-1.82.

The industry rank for Sunniva's Net-Net Working Capital or its related term are showing as below:

XCNQ:SNN's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.74
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Sunniva Net-Net Working Capital Historical Data

The historical data trend for Sunniva's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Net-Net Working Capital Chart

Sunniva Annual Data
Trend Dec16 Dec17 Dec18
Net-Net Working Capital
-0.06 -0.89 -0.89

Sunniva Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.97 -0.89 -1.16 -1.50 -1.82

Competitive Comparison of Sunniva's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Sunniva's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunniva's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunniva's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Sunniva's Price-to-Net-Net-Working-Capital falls into.



Sunniva Net-Net Working Capital Calculation

Sunniva's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2018 is calculated as

Net-Net Working Capital(A: Dec. 2018 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.141+0.75 * 2.955+0.5 * 4.24-40.307
-0-0)/38.0838
=-0.89

Sunniva's Net-Net Working Capital (NNWC) per share for the quarter that ended in Sep. 2019 is calculated as

Net-Net Working Capital(Q: Sep. 2019 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.304+0.75 * 3.888+0.5 * 2.914-76.213
-0-0)/39.2065
=-1.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Sunniva  (XCNQ:SNN) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Sunniva Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Sunniva's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunniva (XCNQ:SNN) Business Description

Industry
Traded in Other Exchanges
N/A
Address
200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2
Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.
Executives
Mark Hamish Kimmins Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Sunniva (XCNQ:SNN) Headlines

From GuruFocus

Smith & Nephew Is Reverting to Fair Value

By Praveen Chawla • 01-25-2023

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter • 08-09-2022